Changes in lipid metabolism in chronic hepatitis C

被引:32
作者
Jarmay, Katalin [1 ]
Karacsony, Gizella [1 ]
Nagy, Andras [2 ]
Schaff, Zsuzsa [3 ]
机构
[1] Albert Szent Gyorgyi Med Univ, Dept Internal Med 1, H-6701 Szeged, Hungary
[2] Cty Hosp, Dept Cardiol, Kecskemet, Hungary
[3] Semmelweis Univ, Dept Pathol 2, Budapest, Hungary
关键词
Lipid metabolism; Chronic hepatitis C; NAFLD;
D O I
10.3748/wjg.v11.i41.6422
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate the relationship between certain biochemical parameters of lipid metabolism in the serum and steatosis in the liver. METHODS: The grade of steatosis (0-3) and histological activity index (HAI, 0-18) in liver biopsy specimens were correlated with serum alanine aminotransferase (ALT), total cholesterol and triglyceride levels in 142 patients with chronic hepatitis C (CH-C), and 28 patients with non-alcoholic fatty liver disease (NAFLD) without hepatitis C virus (HCV) infection. The serum parameters were further correlated with 1 797 age and sex matched control patients without any liver diseases. RESULTS: Steatosis was detected in 90 out of 142 specimens (63%) with CH-C. The ALT levels correlated with the grade of steatosis, both in patients with CH-C and NAFLD (P < 0.01). Inserting the score values of steatosis as part of the HAI, correlation with the ALT level (P < 0.00001) was found. The triglyceride and cholesterol levels were significantly lower in patients with CH-C (with and without steatosis), compared to the NAFLD group and to the virus-free control groups. CONCLUSION: Our study confirms the importance of liver steatosis in CH-C which correlates with lower lipid levels in the sera. Inclusion of the score of steatosis into HAI, in case of CH-C might reflect the alterations in the liver tissue more precisely, while correlating with the ALT enzyme elevation. (C) 2005 The WJG Press and Elsevier Inc. All rights reserved.
引用
收藏
页码:6422 / 6428
页数:7
相关论文
共 40 条
  • [1] Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity
    Adinolfi, LE
    Gambardella, M
    Andreana, A
    Tripodi, MF
    Utili, R
    Ruggiero, G
    [J]. HEPATOLOGY, 2001, 33 (06) : 1358 - 1364
  • [2] Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C
    Asselah, T
    Boyer, N
    Guimont, MC
    Cazals-Hatem, D
    Tubach, F
    Nahon, K
    Daïkha, H
    Vidaud, D
    Martinot, M
    Vidaud, M
    Degott, C
    Valla, D
    Marcellin, P
    [J]. GUT, 2003, 52 (11) : 1638 - 1643
  • [3] Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets
    Barba, G
    Harper, F
    Harada, T
    Kohara, M
    Goulinet, S
    Matsuura, Y
    Eder, G
    Schaff, Z
    Chapman, MJ
    Miyamura, T
    Brechot, C
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (04) : 1200 - 1205
  • [4] Effect of combined interferon-α induction therapy and ribavirin on chronic hepatitis C virus infection:: a randomized multicentre study
    Bjoro, K
    Bell, H
    Hellum, KB
    Skaug, K
    Raknerud, N
    Sandvei, P
    Doskeland, B
    Mæland, A
    Lund-Tonnesen, S
    Myrvang, B
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2002, 37 (02) : 226 - 232
  • [5] Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies
    Castéra, L
    Hézode, C
    Roudot-Thoraval, F
    Bastie, A
    Zafrani, ES
    Pawlotsky, JM
    Dhumeaux, D
    [J]. GUT, 2003, 52 (02) : 288 - 292
  • [6] EDER G, 1994, ROLE OF THE CHIMPANZEE IN RESEARCH, P156
  • [7] Liver steatosis and chronic hepatitis C: A spurious association?
    Fiore, G
    Fera, G
    Napoli, N
    Vella, F
    Schiraldi, O
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1996, 8 (02) : 125 - 129
  • [8] The impact of diabetes and obesity on liver histology in patients with hepatitis C
    Friedenberg, F
    Pungpapong, S
    Zaeri, N
    Braitman, LE
    [J]. DIABETES OBESITY & METABOLISM, 2003, 5 (03) : 150 - 155
  • [9] Fujie H, 1999, J MED VIROL, V59, P141, DOI 10.1002/(SICI)1096-9071(199910)59:2&lt
  • [10] 141::AID-JMV3&gt